Verinurad with febuxostat significantly reduces albuminuria and hyperuricaemia in patients with type 2 diabetes
The results of a phase IIa clinical trial presented today at the Annual European Congress of Rheumatology (EULAR 2019) demonstrate a rapid reduction in albuminuria and hyperuricaemia in patients with type II diabetes with ...
Jun 13, 2019
0
0